Picture of Biocartis NV logo

BCART — Biocartis NV News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareBalancedMicro Cap

Brief: Biocartis Group Says Idylla™ Allows Rapid and Accurate Mutation Testing Results

June 26 (Reuters) - BIOCARTIS GROUP NV  BCART.BR :
    * US MULTICENTER STUDY SHOWS IDYLLA™ ALLOWS RAPID AND
ACCURATE
MUTATION TESTING RESULTS ACROSS DIFFERENT LABORATORY SETTINGS
    * STUDY SHOWS THAT, COMPARED TO CURRENT STANDARD-OF-CARE
TESTING
METHODS, BIOCARTIS' IDYLLA™ CAN SUBSTANTIALLY IMPROVE TURNAROUND
TIME OF RESULTS OF MUTATION TESTING
    * RESEARCHERS FOUND THAT AVERAGE TURNAROUND TIME FOR TEST
RESULTS
COULD BE CUT BY MORE THAN 50% FROM 15 DAYS TO 5 DAYS, WITH SOME
RESULTS AVAILABLE IN A SINGLE DAY, WITH IDYLLA

Source text for Eikon:  ID:nGNE9DdfpK 
Further company coverage:  BCART.BR 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Biocartis NV

See all news